(Q43949796)

28 November 2017

title

Limited sampling strategy to predict AUC of the CYP3A phenotyping probe midazolam in adults: application to various assay techniques (English)

1 reference

28 November 2017

1 reference

11

David J Greenblatt

1 reference

28 November 2017

7

Robert W Kulawy

1 reference

28 November 2017

6

Angela D M Kashuba

1 reference

28 November 2017

Jooran S Kim

1

1 reference

28 November 2017

Anne N Nafziger

2

1 reference

28 November 2017

Shirley M Tsunoda

3

1 reference

28 November 2017

Edna E Choo

4

1 reference

28 November 2017

Daniel S Streetman

5

1 reference

28 November 2017

Debra J Beck

8

1 reference

28 November 2017

Mario L Rocci

9

1 reference

28 November 2017

Grant R Wilkinson

10

1 reference

28 November 2017

Joseph S Bertino

12

1 reference

28 November 2017

publication date

1 April 2002

1 reference

The Journal of Clinical Pharmacology

28 November 2017

published in

1 reference

28 November 2017

volume

42

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

376-382

1 reference

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Limited sampling models for doxorubicin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Simplified approaches to the determination of antipyrine pharmacokinetic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Comparison and validation of limited sampling equations for cyclosporine area-under-the-curve monitoring calculations in pediatric renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Quantitation by gas chromatography of the 1- and 4-hydroxy metabolites of midazolam in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

NCOMP--a windows-based computer program for noncompartmental analysis of pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Some suggestions for measuring predictive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

A limited sampling model for the pharmacokinetics of etoposide given orally.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

A limited sampling method for estimation of the carboplatin area under the curve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Determination of drug-metabolizing enzyme activity in vivo: pharmacokinetic and statistical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Methotrexate in rheumatoid arthritis--a limited sampling strategy for estimation of the area under the plasma concentration versus time curve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

A limited-sampling method for evaluation of the area under the curve of ultrafilterable carboplatin in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Limited sampling models for reliable estimation of etoposide area under the curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

A limited sampling method for estimation of the etoposide area under the curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

A comparative computer simulation study of three different sparse-sampling methods for the estimation of steady-state area under the concentration-time curve (AUC) and maximum concentration (Cmax) in toxicokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Development of a limited sampling approach in pharmacokinetic studies: experience with the antiepilepsy drug tiagabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

Population pharmacokinetics of midazolam in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011418

10.1177/00912700222011418

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference